Enhancing Stem Cell Mobility: New Hope for Treatment of Cardiovascular Complications in Patients With Diabetes?

Diabetes. 2015 Aug;64(8):2704-7. doi: 10.2337/db15-0433.

Authors

Gaia Spinetti¹, Giuseppe Mangialardi², Claudia Specchia³, Paolo Madeddu⁴

Affiliations

¹ IRCCS MultiMedica, Milan, Italy.
² Bristol Heart Institute, University of Bristol, Bristol, U.K.
³ IRCCS MultiMedica, Milan, Italy University of Brescia, Brescia, Italy.
⁴ Bristol Heart Institute, University of Bristol, Bristol, U.K. [email protected].

PMID: 26207034
DOI: 10.2337/db15-0433

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus, Type 1 / therapy*
Female
Granulocyte Colony-Stimulating Factor / pharmacology*
Hematopoietic Stem Cell Mobilization*
Hematopoietic Stem Cells / drug effects*
Heterocyclic Compounds / pharmacology*
Humans
Male

Substances

Heterocyclic Compounds
Granulocyte Colony-Stimulating Factor

Grants and funding